|
Market Cap (25-Jun) $125,067,280 (1,258th) |
Close (30-Jun) $0.007 |
Volume (30-Jun) 188,484 |
Shortsold (14-May) 14,985,846 (0.14%) (426th) |
|
52w High $0.85 |
52w Low $0.350 |
P/E 10.33 |
EPS -0.07 |
ATH released this announcement to the ASX on 17 December 2020, 10:07. The announcement is not marked as price sensitive, and is 32 page(s) in length and 663.67kb in size.
You can view all announcements from ATH and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATH was 0.118% short sold according to ASIC data. It was ranked the 406th most shorted stock on the ASX. It remains ranked 426th as of the latest reported data (14 May 2026).
| Other Recent Announcements from ATH | |
|---|---|
| Investor Presentation | 22 June 2023, 11:13 |
| ATH to present at MST Rare Diseases Rich Returns Forum | 21 June 2023, 9:52 |
| ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder | 30 May 2023, 13:32 |
| Prospectus Supplement | 17 December 2020, 10:07 |
| Change in substantial holding | 10 December 2020, 8:22 |
| Change in substantial holding | 4 December 2020, 8:20 |
| Form S-8 | 3 December 2020, 9:48 |
You must be logged in to post a reply.
Alterity Therapeutics 